MR-guided proton therapy: a review and a preview.
Aswin HoffmannBradley ObornMaryam MoteabbedSusu YanThomas BortfeldAntje KnopfHerman FuchsDietmar GeorgJoao SecoMaria Francesca SpadeaOliver JäkelChristopher KurzKatia ParodiPublished in: Radiation oncology (London, England) (2020)
Although MRiPT is still in its infancy, significant progress on all four aspects has been made, showing promising results that justify further efforts for research and development to be undertaken. First non-clinical research solutions have recently been realized and are being thoroughly characterized. The prospect that first prototype MRiPT systems for clinical use will likely exist within the next 5 to 10 years seems realistic, but requires significant work to be performed by collaborative efforts of research groups and industrial partners.